The ultrasound findings of the pelvis, upper abdomen and peritoneal cavity were correlated with second-look laparotomy in 85 patients with Stage III or Stage IV ovarian carcinoma. High values of accuracy were obtained for the pelvis (90%) and liver (91 %) but ultrasound was insensitive to peritoneal disease unless ascites was present.
Introduction
One of the earliest applications of diagnostic ultrasound was in the field of obstetrics. More recently the technique has been used to evaluate pelvic disease, including malignant disorders (Cochrane & Thomas 1974 , Morley & Barnett 1970 . Carcinoma of the ovary is the commonest fatal gynaecological cancer in the West, with an incidence that has been rising over the past decade (Young 1975 , Young & Fisher 1978 . It is generally accepted -that ultrasound has only a limited role in the initial or preoperative management of this condition. This is because a histological diagnosis is usually required before treatment decisions can be made, and ultrasound is unable to differentiate between benign and malignant ovarian masses. Consequently, laparotomy must be performed to obtain this information. The most important role that ultrasound plays in the initial management of such patients is the assessment of the primary site of the disease and its extension into the pelvic, abdominal and retroperitoneal regions (Lawson & Albarelli 1977 , Levi & Delval 1976 . Once initial surgery has been performed, ultrasound is of value in monitoring response to therapy of any residual pelvic disease and in detecting and staging tumour recurrence.
The opportunity to test the accuracy of ultrasound in Stage III and Stage IV ovarian cancer arose in a group of patients who were scanned at intervals from the time of primary surgery until a short period before second-look laparotomy was performed. We correlate here the second-look laparotomy findings with ultrasound for the pelvis and abdomen in these patients.
Methods
Eighty-five patients between the ages of 29 and 75 years (mean age 55) who had second-look laparotomy had ultrasound examination following surgery. The histology of the ovarian tumours obtained at the time of initial surgery is shown in Table 1 . All patients in the study had Stage III or IV disease (Table 2) or recurrent tumour following previous surgery and radiotherapy. . Second-look laparotomy was performed for assessment, debulking or removal of residual disease in patients who were apparently responding to chemotherapy. In all but 3 cases the ultrasound examination was performed within four weeks of surgery. The results from these 
Definition
Growth confined to ovaries Growth involving one or both ovaries with pelvic extension Growth involving one or both ovaries with intraperitoneal spread outside the pelvis and/or positive retroperitoneal nodes Growth involving one or both ovaries with distant metastases patients were not included in the data analysis, and the study was therefore confined to 82 cases. All ultrasound examinations were performed using a standard technique with both real time and grey scale B-mode scanners. Real-time imaging was performed using either an EMI 4500 Emisonic scanner or a General Electric (Datason) mechanical sector scanner. Bmode scanning was accomplished with a custom-built scanner and the General Electric Datason scanner with a 5.0 MHz transducer. All patients were required to have a full bladder and received an aperient 24 hours beforehand to stimulate gut peristalsis to enable differentiation between bowel and tumour masses on real time scanning. Multiple tomographic sections were obtained of the pelvis and abdomen in transverse and sagittal planes. The kidneys were also examined for hydronephrosis. The data were analysed as falling within three categories -concordant, discordant or equivocal. The findings obtained at laparotomy were then used to calculate the sensitivity, specificity and accuracy of ultrasound, by means of the following equations: 
Results
Of the 85 patients studied, there were unsuccessful ultrasound examinations of the pelvis in 6 (7%) and of the upper abdomen in 4 (5%) ( Table 3 ). The para-aortic region could not be assessed in all cases but it was possible in 3 of these cases to visualize the liver.
Ultrasound results were compared with laparotomy in the pelvis, liver and peritoneal cavity. Pelvic disease was considered to be present if a pelvic mass was documented at (Table 4 ). In 7 cases the results were discordant. Of the 3 false positive reports, 2 were due to adherent bowel loops simulating tumour recurrence; in one patient it was not known at the time of ultrasound that the uterus was in situ and this was misdiagnosed as tumour recurrence ( Figure I ). False negative results occurred in 2 patients in whom the bladder was inadequately filled at the time of study, in one with a sheet of tumour and in one with a mass in the iliac fossa. There were 6 equivocal results (5 ultrasound, I laparotomy), of which 4 were due to the inability of ultrasound to differentiate between tumour recurrence and loops of bowel. '
In the remaining 70 cases in which direct comparison between ultrasound and laparotomy was possible for the pelvis (see also Table 3 ), the overall accuracy of ultrasound was found to be 90%. The sensitivity and specificity values were 91% and 88% respectively. Tumour recurrence appeared as an echo-poor region on ultrasound (Figure 2 ). In the majority of cases it was possible to distinguish tumour recurrence from loops of bowel since the latter demonstrated peristaltic movements and produced echoes of higher amplitude.
As an additional exercise we attempted to correlate residual tumour size found at laparotomy with measurements obtained by ultrasound. There were only 10 cases in which tumour sizes were accurately recorded at laparotomy. The values are compared with ultrasound measurements in Table 5 . There were 7 cases where ultrasound overestimated tumour size but in 3 cases the converse was true. The mean difference in tumour size obtained between ultrasound and laparotomy was +0.75 cm. (8), was mistaken for a large recurrent tumour. It was in fact due to a bulky uterus which was still in situ but this information was not known at the time of examination Figure 2 . A: Transverse tomogram of the pelvis in patient with cystadenocarcinoma of the ovary si~months following hysterectomy and bilateral salpingo-oophorectomy. An echo-poor mass (M), 5 x 5 em, partly cystic in nature and situated behind the bladder, was reported as consistent with tumour recurrence. Second-look laparotomy performed two weeks later confirmed its presence. B: Mixed solid-cystic mass (arrow) diagnosed on ultrasound (transverse scan) was confirmed at laparotomy one week later.
The data for the liver were concordant in 72 cases (Table 4) , with discordant results being obtained in 7 cases (9%). In the one false positive case, a suspected tumour deposit was shown by liver biopsy to be a haemangioma. The 6 false negative reports comprised 3 cases in which the tumour sizes were less than I em, one case where a tumour deposit was missed on the anterior surface of liver closely apposed to the diaphragm, and 2 cases where tumour masses were felt at laparotomy but not biopsied.
For the liver, ultrasound produced an overall accuracy of 91 %, sensitivity of detection of 63% and specificity of 98%. The majority of intrahepatic metastases were multiple and predominantly echo-poor. Cystic, solid and mixed solid cystic metastatic lesions were seen ( Figure 3A) .
Results for the peritoneal cavity showed excellent agreement between ultrasound and laparotomy for documenting the presence or absence of ascites (Table 4 ). For ultrasound the overall accuracy was 97%, sensitivity 90% and specificity 98%. In a number of cases ascites was detected by ultrasound but not on routine clinical examination. There were 22 cases in which peritoneal seedlings were detected at laparotomy, but ultrasound failed in every This abnormality was thought to represent a large cystic deposit within the liver but laparotomy showed it to be an area of loculated ascites instance to detect these. Ascites was present in 60% of cases with peritoneal seedlings. In only one out of 7 cases in which an omental mass was found at laparotomy was ultrasound able to document its presence.
Discussion
These results show that ultrasound is a reliable method for detecting recurrence of ovarian carcinoma in the pelvis and for monitoring the progress of disease in the pelvis and upper abdomen following treatment. When residual pelvic disease is known to be present after initial surgery, or when tumour recurrence occurs, ultrasound provides an objective and reasonably accurate method of sizing the tumour mass. However, in the small number of patients studied, ultrasound was found to overestimate tumour size slightly, and the reason for this is unclear. It is possible that recurrent ovarian tumours evoke an inflammatory process in the pelvis. This is a recognized observation which occurs, for example" with pancreatic tumours (Weill 1978) . If an associated inflammatory response is present then this may result in the tumour appearing larger than its true size on ultrasound examination. A further possible explanation is that whenever recurrent tumours are very closely applied to bowel loops, shadowing from the bowel may lead to difficulty in visualizing the true outline Figure 4 . A: Echo-poor region (2 em) at the vault ofthe vagina (arrow). This mass was impalpable clinically. Laparoscopy confirmed tumour recurrence at this site. One month later following chemotherapy the mass had reduced to approximately half its original size (B). Figure 5 . Large, predominantly echo-poor, lobulated mass (M) in the mid-abdomen was found at surgery to be an omental deposit of the echo-poor tumour mass on ultrasound. This could result in.. an apparent overestimation of tumour size. In 3 cases ultrasound underestimated tumour size; the reason for this finding is not understood.
In the pelvis, ultrasound proved a useful adjunct and in many instances supplemented the clinical examination. In a number of cases ultrasound was able to document laparotomyproven tumour masses which were impalpable clinically ( Figure 4) . In other cases, masses which were palpated on clinical examination and thought to represent recurrent disease were shown on ultrasound to be due to bowel loops, resolving haematoma, and very occasionally to thickening of the vault of the vagina.
In the upper abdomen, ultrasound detected liver metastases with a high degree of accuracy but its sensitivity of detection was less impressive. A difficulty for ultrasound is in distinguishing surface metastases from peritoneal deposits. Rarely, a subcapsular cystic deposit was confused with a subdiaphragmatic collection of loculated ascitic fluid ( Figure  38 ). Ultrasound was also found to supplement clinical examination of the liver. In a number of cases liver deposits which were not detected on clinical examination were documented by ultrasound and subsequently confirmed at laparotomy.
Ovarian cancer may implant throughout the peritoneal cavity, forming metastatic nodules within the mesentery, omentum and peritoneal lining ( Figure 5 ). Ultrasound is an unreliable method for detecting the spread of ovarian cancer in the peritoneal cavity unless ascites is present ( Figure 6A ). However, ascites alone is an unreliable indicator of peritoneal disease since peritoneal seedlings may occur with or without ascites. Indeed, only 60% of patients with peritoneal seedlings in this series were found to have ascites at laparotomy. Ultrasound will, however, accurately detect small quantities of ascitic fluid which are clinically undetectable ( Figure 6B ). Peritoneal seedlings are nearly always very small and below the resolution of the scanning equipment. Abdominal gas also obscures detection in the majority of cases unless the seedlings are in the upper abdomen close to the diaphragmatic surface where they may be difficult to differentiate from metastases on the liver surface.
Peritoneal disease is reported to be reliably documented at laparoscopy (Rosenoff et al. 1975 , Spinelli et al. 1976 ). If ultrasound is combined with laparoscopy, this should theoretically provide high accuracy rates for detecting disease of the peritoneum and possibly also of the pelvis and upper abdomen (Mangioni et al. 1979) . This combined, relatively noninvasive approach may therefore spare some patients, who are clinically tumour-free, the need for a second-look laparotomy, However, the limitations of ultrasound and laparoscopy as techniques for documenting disease in the pelvis and abdomen must be remembered.
The results obtained with ultrasound in the management of patients with ovarian carcinoma are very encouraging. The technique can be used to document the efficacy of chemotherapeutic agents and for assessing whether further debulking surgery might be required. In those patients who are clinically tumour-free and in whom the ultrasound examination is also negative, only laparoscopy might be required for assessment of the peritoneal cavity.
